• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Induction of apoptosis in gynecologic cancer cells by the soluble IGF-I receptor.

Research Project

Project/Area Number 10671544
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Obstetrics and gynecology
Research InstitutionOkayama University

Principal Investigator

HONGO Atsushi  Medical Hospital, Okayama University assistant, 医学部・附属病院, 助手 (10301293)

Co-Investigator(Kenkyū-buntansha) YOSHINOUCHI Mitsuo  Medical Hospital, Okayama University assistant professor, 医学部・附属病院, 講師 (50261235)
MIYAGI Yasunari  Medical Hospital, Okayama University assistant, 医学部・附属病院, 助手 (10273989)
KODAMA Junichi  Medical Hospital, Okayama University assistant, 医学部・附属病院, 助手 (90263582)
KUDO Takafumi  Medical School, Okayama University professor, 医学部, 教授 (90127556)
OKUDA Hiroyuki  Medical School, Okayama University professor, 医学部, 教授 (30033286)
Project Period (FY) 1998 – 1999
KeywordsIGF-I receptor / IGF-I / transformation / tumorigenicity / apoptosis / chemosensitivity / bystander effect
Research Abstract

1) In order to evaluate the anti-tumor effect of the IGF-I receptor blockage in gynecologic malignancies, We transfected an antisense mRNA expression vector into human cervical cancer derived cell lines, SiHa, HeLa S3, and C33A and established stable transformants. Introduction of the antisense slightly inhibited growth in mono-layer and makedly inhibited anchorage-independent growth in soft agar and tumorigenicity in nude mice. These results were presented at the 90th annual meeting of AACR (Philadelphia PA, USA) and published in Cancer Research.
2) Then we tried to use the soluble IGF-I receptor with a bystander effect that would be an advantage in clinical applications. We stably transfected the soluble IGF-I receptor in human ovarian carcinoma derived cell line CaOV-3. The soluble receptor was detected as a 70kDa protein from total cell lysates as well as conditioned media. Anchorage-independent growth of the soluble IGF-I receptor clones was strongly inhibited and conditioned media from transfected clones showed bystander effects. Tumorigenicity in nude mice was abrogated in transfected clones and co-culture of the parental cells with transfected clones showed bystander effects in vivo. Chemosensitivity against paclitaxel was tested by clonogenic assay and transfected clones showed much higher sensitivities. Percentages of the apoptotic cells after paclitaxel treatment were significantly higher in transfected clones ; indicating the abrogation of the anti-apoptotic activity of the IGF-I receptor caused this effect. These results were presented at the 5th International Symposium on IGFs (Brighton, UK), the 92nd annual meeting of AACR (New Orleans LA, USA) and submitted for publication

  • Research Products

    (8 results)

All Other

All Publications (8 results)

  • [Publications] Atsushi Hongo, Keiichiro Nakamura, Mitsuo Yoshinouchi, and Takafumi Kudo.: "Downregulation of the insulin-like growth factor I receptor by antisense can reversetransformed phenotypes of HPV positive and negative human cervical cancer cell lines."Proceedings AACR. 40. 174 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Atsushi Hongo, Keiichiro Nakamura, Mitsuo Yoshinouchi, and Takafumi Kudo.: "A Soluble Insulin-like Growth Factor I Receptor Inhibits Transformation and Sensitizes CaOV-3 Human Ovarian Carcinoma Cells to Cisplatin and Taxol."Growth Hormone & IGF Research. 9. 340-341 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Keiichiro Nakamura, Atsushi Hongo, Junichi Kodama, Yasunari Miyagi, Mitsuo Yoshinouchi, and Takafumi Kudo.: "Down-Regulation of the Insulin-like Growth Factor I Receptor by Antisense RNA Can Reverse the Transformed Phenotype of Human Cervical Cancer Cell Lines."Cancer Research. 60. 760-765 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Atsushi Hongo, Hiroyuki Kuramoto, and Takafumi Kudo.: "A Soluble Insulin-like Growth Factor I Receptor Inhibits Tumorigenicity of CaOV-3 Human Ovarian Cancer Cells with a Bystander Effect and Increases Their Chemosensitivity to Paclitaxel."Proceedings AACR. 42. 775 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Atsushi Hongo, Keiichiro Nakamura, Mitsuo Yoshinouchi and Takafumi Kudo: "Downregulation of the insulin-like growth factor I receptor by antisense can reversetransformed phenotypes of HPV positive and negative human cervical cancer cell lines."Proceedings AACR. 40. 174 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Atsushi Hongo, Keiichiro Nakamura, Mitsuo Yoshinouchi, and Takafumi Kudo: "A Soluble Insulin-like Growth Factor I Receptor Inhibits Transformation and Sensitizes CaOV-3 Human Ovarian Carcinoma Cells to Cisplatin and Taxol."Growth Hormone & IGF Research. 9. 340-341 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Keiichiro Nakamura, Atsushi Hongo, Junichi Kodama, Yasunari Miyagi, Mitsuo Yoshinouchi, and Takafumi Kudo: "Down-Regulation of the Insulin-like Growth Factor I Receptor by Antisense RNA Can Reverse the Transformed Phenotype of Human Cervical Cancer Cell Lines."Cancer Research. 60. 760-765 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Atsushi Hongo, Hiroyuki Kuramoto, and Takafumi Kudo: "A Soluble Insulin-like Growth Factor I Receptor Inhibits Tumorigenicity of CaOV-3 Human Ovarian Cancer Cells with a Bystander Effect and Increases Their Chemosensitivity to Paclitaxel."Proceedings AACR. 42. 775 (2001)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi